Clinical Trials for Autoimmune Lymphoproliferative Syndrome

Find clinical trials for autoimmune lymphoproliferative syndrome. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

NCT ID: NCT06730126

This clinical trial is studying a medication called soquelitinib to see if it can help reduce the number of immune cells in people with Autoimmune Lymphoproliferative Syndrome (ALPS), a rare immune...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States, Houston, Texas, United States +1 more

Immune Disorder HSCT Protocol

NCT ID: NCT01821781

This clinical trial is studying a new treatment approach for patients with certain immune deficiency disorders, which are conditions where the immune system does not work properly. The goal is to s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Saint Louis, Missouri, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions